David S.C. Hui

83.6k total citations · 14 hit papers
420 papers, 27.9k citations indexed

About

David S.C. Hui is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David S.C. Hui has authored 420 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Infectious Diseases, 149 papers in Pulmonary and Respiratory Medicine and 120 papers in Epidemiology. Recurrent topics in David S.C. Hui's work include SARS-CoV-2 and COVID-19 Research (89 papers), Respiratory viral infections research (76 papers) and COVID-19 Clinical Research Studies (75 papers). David S.C. Hui is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (89 papers), Respiratory viral infections research (76 papers) and COVID-19 Clinical Research Studies (75 papers). David S.C. Hui collaborates with scholars based in Hong Kong, China and United States. David S.C. Hui's co-authors include Alimuddin Zumla, Fanny W.S. Ko, Joseph J.�Y. Sung, Nelson Lee, Paul K.S. Chan, Alan Wu, Esam I. Azhar, Susanna S. Ng, Stanley Perlman and Kwok‐Yung Yuen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David S.C. Hui

401 papers receiving 27.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

2003 1.9k citations Nelson Lee, David S.C. Hui et al. profile →
Coronaviruses — drug discovery and therapeutic options

2016 1.3k citations Alimuddin Zumla, Esam I. Azhar et al. profile →
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

2004 996 citations Chun Kwok Wong, Nelson Lee et al. profile →
Middle East respiratory syndrome

2015 938 citations Alimuddin Zumla, David S.C. Hui et al. profile →
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

2010 834 citations David S.C. Hui et al. profile →
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

2015 505 citations David S.C. Hui et al. profile →
Severe Acute Respiratory Syndrome

2019 363 citations David S.C. Hui, Alimuddin Zumla profile →
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

2022 351 citations Qin Liu, Joyce Wing Yan Mak et al. Gut profile →
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

2018 311 citations David S.C. Hui, Esam I. Azhar et al. profile →
Influenza

2022 281 citations David S.C. Hui et al. profile →
Exhaled air dispersion during high-flow nasal cannula therapyversusCPAPviadifferent masks

2019 217 citations David S.C. Hui, Fanny W.S. Ko et al. profile →
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

2022 211 citations Samuel M. S. Cheng, Chris Ka Pun Mok et al. Nature Medicine profile →
Neutralizing antibody titres in SARS-CoV-2 infections

2021 209 citations Eric H. Y. Lau, Owen TY Tsang et al. Nature Communications profile →
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

2023 116 citations Samuel M. S. Cheng, Kathy Leung et al. Nature Medicine profile →

Peers

Countries citing papers authored by David S.C. Hui

Since Specialization

Citations

This map shows the geographic impact of David S.C. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S.C. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S.C. Hui more than expected).

Fields of papers citing papers by David S.C. Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S.C. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S.C. Hui. The network helps show where David S.C. Hui may publish in the future.

Co-authorship network of co-authors of David S.C. Hui

This figure shows the co-authorship network connecting the top 25 collaborators of David S.C. Hui. A scholar is included among the top collaborators of David S.C. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S.C. Hui. David S.C. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Host Immunomodulatory Interventions in Severe Influenza 2025 ·The Journal of Infectious Diseases ·David S.C. Hui, Ka Pang Chan	5
2	SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study 2025 ·Nature Communications ·Ka Chun Chong, (unknown), Katherine Min Jia, Christopher Boyer, (unknown), Huwen Wang, (unknown), Chi Tim Hung, Xiaoting Jiang, Carrie Ho Kwan Yam, (unknown), Yawen Wang, Shi Zhao, (unknown), Aimin Yang, Chris Ka Pun Mok, David S.C. Hui, Eng‐Kiong Yeoh, Zihao Guo	2
3	Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination 2024 ·Influenza and Other Respiratory Viruses ·(unknown), Samuel M. S. Cheng, (unknown), (unknown), (unknown), (unknown), John K. C. Li, David S.C. Hui, Malik Peiris, Hui‐Ling Yen	3
4	Perspectives on development and advancement of new tuberculosis vaccines 2024 ·International Journal of Infectious Diseases ·Christopher da Costa, Christine Stabell Benn, Thomas Nyirenda, Evans Mpabalwani, Harleen M. S. Grewal, Rizwan Ahmed, Nathan Kapata, Peter S. Nyasulu, Markus Maeurer, David S.C. Hui, Delia Goletti, Alimuddin Zumla	10
5	A 5‐year perspective on coronavirus diseases 2019 (COVID‐19) 2024 ·Respirology ·David S.C. Hui, Alimuddin Zumla	2
6	Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine 2024 ·Journal of Infection ·Chris Ka Pun Mok, (unknown), Chee Wah Tan, Ka Chun Chong, Chunke Chen, Yuanxin Sun, Karen Yiu, (unknown), Ka Pang Chan, David S.C. Hui	1
7	Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19 2024 ·Metabolites ·Zigui Chen, Erik Fung, Chun Kwok Wong, Lowell Ling, Grace Lui, Christopher K.C. Lai, Rita W. Y. Ng, (unknown), Wendy C. S. Ho, David S.C. Hui, Paul K.S. Chan	2
8	Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes 2023 ·JAMA Network Open ·(unknown), Terry Cheuk‐Fung Yip, Grace Lui, (unknown), (unknown), Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, David S.C. Hui, Timothy Kwok, Grace Lai–Hung Wong	9
9	Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment 2023 ·Frontiers in Cellular and Infection Microbiology ·Lowell Ling, Christopher K.C. Lai, Grace Lui, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wai‐Tat Wong, David S.C. Hui, Chun Kwok Wong, Paul K.S. Chan, Zigui Chen	3
10	Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins 2023 ·International Journal of Infectious Diseases ·Esam I. Azhar, Thirumalaisamy P. Velavan, (unknown), (unknown), David S.C. Hui, Brian McCloskey, Sherif A. El‐Kafrawy, Alimuddin Zumla	11
11	Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population breakdown → 2023 ·Nature Medicine ·(unknown), Samuel M. S. Cheng, Kathy Leung, Cheuk Kwong Lee, Asmaa Hachim, Leo C. H. Tsang, (unknown), Sara Chaothai, Kelvin K. H. Kwan, (unknown), (unknown), Masashi Mori, Chao Wu, Sophie A. Valkenburg, Gaya K. Amarasinghe, Eric H. Y. Lau, David S.C. Hui, GM Leung, Malik Peiris, Joseph T. Wu	116
12	Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients 2022 ·SHILAP Revista de lepidopterología ·Ngai Sze Wong, Shui Shan Lee, Denise Pui Chung Chan, (unknown), (unknown), (unknown), Kai Ming Chow, Eugene Y. K. Tso, Eng‐Kiong Yeoh, Samuel Yeung Shan Wong, David S.C. Hui, Grace Lui	1
13	Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients 2022 ·Gut Microbes ·Qi Su, Qin Liu, Lin Zhang, Zhilu Xu, Chen-Yu Liu, Wenqi Lu, Jessica Y. L. Ching, Amy Li, Joyce Wing Yan Mak, Grace Lui, Susanna S. Ng, Kai Ming Chow, David S.C. Hui, Paul K.S. Chan, Francis K.L. Chan, Siew C. Ng	10
14	Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events 2022 ·Gut ·Siew C. Ng, Ye Peng, Lin Zhang, (unknown), Shilin Zhao, Amy Li, Jessica Y. L. Ching, Yingzhi Liu, Shuai Yan, (unknown), Jie Zhu, Chunke Chen, Adrian Chi Heng Fung, Kenneth KY Wong, David S.C. Hui, Francis K.L. Chan, Hein M. Tun	111
15	Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong 2021 ·Respirology ·Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M. S. Cheng, Chunke Chen, Kin On Kwok, Karen Yiu, Tat‐On Chan, Maireid Bull, (unknown), (unknown), Susanna S. Ng, Grace Lui, Chao Wu, Gaya K. Amarasinghe, Daisy W. Leung, Samuel Yeung Shan Wong, Sophie A. Valkenburg, Malik Peiris, David S.C. Hui	91
16	Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera 2020 ·Journal of Clinical Microbiology ·Ranawaka A. P. M. Perera, Ronald LW Ko, Owen TY Tsang, David S.C. Hui, Mike Yat Wah Kwan, Christopher J. Brackman, (unknown), Hui‐Ling Yen, Kathy Leung, Samuel M. S. Cheng, Kin Ho Chan, Kaimin Chan, (unknown), Linda J. Saif, Vanessa R. Barrs, Joseph T. Wu, Thomas H. C. Sit, Leo L. M. Poon, Malik Peiris	102
17	High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections 2013 ·Clinical Infectious Diseases ·Nelson Lee, Grace Lui, K. T. Wong, (unknown), (unknown), Jim Yee Him Chan, Janice Yu, Simon S. Wong, Kitty Wai Ying Choi, (unknown), Karry L. K. Ngai, David S.C. Hui, Paul K.S. Chan	255
18	An Adjunct Intervention for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) 2012 ·The Journal of Alternative and Complementary Medicine ·Shirley P.C. Ngai, Alice Jones, C.W.Y. Hui-Chan, Fanny W.S. Ko, David S.C. Hui	13
19	Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. 2009 ·PubMed ·David S.C. Hui, Kainam Thomas Wong, G. E. Antonio, Man Tong, David P. Chan, Joseph J.�Y. Sung	36
20	Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia 2004 ·American Journal of Respiratory and Critical Care Medicine ·Larry M. Baddour, Victor L. Yu, Keith P. Klugman, Charles Feldman, Åke Örtqvist, Jordi Rello, Arthur J. Morris, Carlos M. Luna, David R. Snydman, Wen‐Chien Ko, Maria Bernadete Fernandes Chedid, David S.C. Hui, Antoine Andremont, Christine C. Chiou	301

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact